EU REGULATOR TO PROBE ETHICAL STANDARDS OF SPUTNIK VACCINE TRIALS

The EU drug regulator will launch an investigation next week into whether clinical trials of Russia’s Sputnik V Covid-19 vaccine contravened ethical and scientific standards.

The European Medicines Agency’s probe into whether Sputnik V trials met “good clinical practice” standards comes as people familiar with the regulator’s approval process told the Financial Times of their concerns that they had not been ethically run.

GCP is an internationally agreed standard aimed at ensuring that drug trials are designed and conducted properly. Russia has said military servicemen and state employees were involved in trials of the jab developed by a state-run laboratory and funded by the Russian Direct Investment Fund, the Kremlin’s sovereign wealth fund. The Reuters news agency has reported that some who took part described being pressured to do so by their superiors.

 

Source: Financial Times